The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement

Rheumatology International

Volumn 27, Issue 2, 2006, Pages 163-167

  Musellim, Benan ^a   Ikitimur, Hande ^a   Uzun, Hafize ^a   Ongen, Gul ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Oxidants; Systemic sclerosis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; MALONALDEHYDE; NITRIC OXIDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC SCLEROSIS; VITAMIN BLOOD LEVEL;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SCLERODERMA, SYSTEMIC;

EID: 33846174285     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0184-6     Document Type: Article

References (32)

1. Freemer MM, King TE Jr (2003) Connective tissue diseases. In: Schwarz MI, King TE Jr (eds) Interstitial lung disease. Decker Inc, London BC, pp 535-598
2. Del Maestro RF, Thaw HH, Bjork J et al (1980) Free radicals as mediators of tissue injury. Acta Physiol Scand 492:43-57
3. Simonini G, Pignone A, Generini S et al (2000) Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 155:1-15
4. Murrell GAC, Francis MJO, Bromley L (1990) Modulation of fibroblasts proliferation by oxygen free radicals. Biochem J 265:659-665
5. Simoni G, Cerinic MM, Generini S et al (1999) Oxidative stress in Systemic Sclerosis. Mol Cellular Biochem 196(1-2):85-91
6. Cracowski JL, Marpeau C, Carpentier PH et al (2001) Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. Arthritis Rheum 44(5):1143-1148
7. Stein CM, Tanner SB, Awad JA et al (1996) Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 39(7):1146-1150
8. Cracowski JL, Carpentier PH, Imbert B et al (2002) Increased urinary F2-isoprostanes in systemic sclerosis but not in primary Raynaud's phenomenon: effect of cold exposure. Arthritis Rheum 46(5):1319-1323
9. Cantin AM, Hubbard RC, Crystal RG (1989) Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139:370-372
10. MacNee W, Rahman I (1995) Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50:553-558
11. Beeh KM, Beier J, Haas IC et al (2002) Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur Respir J 19:1119-1123
12. Behr J, Maier K, Krombach F et al (1991) Pathogenic significance of reactive oxygen species in diffuse fibrosing alveolitis. Am Rev Respir Dis 144:146-50
13. Subcomittee for Scleroderma Criteria of The American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classiffication of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-586
14. Warrick JH, Bhalla M, Schabel AI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18:1520-1528
15. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 12:302-310
16. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126:131-138
17. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500
18. Sun L, Peterson TE, Mc Cormick ML, Oberley LW, Osborne JW (1989) Improved superoxide dismutase assay for clinical use. Clin Chem 35:1265-1266
19. Yasmineh WG, Kaur TP, Blazar BR, Theologides A (1995) Serum catalase as marker of graft-versus-host disease in allogenic bone marrow transplant recipients. Clin Chem 41:1574-1580
20. Quaife ML, Scrimshaw NS, Lowry OH (1949) A micromethod for assay of total tocopherols in blood serum. J Biol Chem 180:1229-1235
21. Omage ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 6:3-13
22. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A (2004) Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am J Med 116(9):595-600
23. Fajoc I, Kahan A, Menkes CJ, Desanges JF, Dall J, Santucci A, Dinh-Xuan AT (1998) Increased NO in exhaled air in patients with SS. Clin Exp Rheumatol 16:547-552
24. Yamamato T, Katayama I, Nishioka K (1998) NO production and inducible NO synthase expression in SS. J Rheumatol 25:314-317
25. Herrick AL, Rieley F, Schofield, Hollis S, Braganza JM, Jayson MIV (1994) Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 21:1477-1483
26. Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheumatol Dis 51:1143-1148
27. Morita A, Minami H, Sakakibara N, Sato K, Tsuji TAD (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196-201
28. Denton CP, Bunce TD, Dorado MB, Roberts Z, Wilson H, Howell K, Bruckdorfer KR, Black CM (1999) Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. Rheumatology 38:309-315
29. Sambo P, Amico D, Giacomelli R, Matucci-Cerinic M, Salsano F, Valentini G, Gabrielli A (2001) Intravenous N-acetylcysteine for treatment of Reynaud's phenomenon secondary to systemic sclerosis: a pilot study. J Rheumatol 28:2257-2262
30. Failli P, Palmieri L, D' Alfonso C, Giovannelli L, Generini S, Rosso AD, Pignone A, Stannlin N, Orsi S, Ziletti L, Matucci-Cerinic M (2002) Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide 7:277-282
31. Clements PJ, Lachenbruch PA, Cheng S, Simmons M, Sterz M, Furst E (1990) Skin score A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 33:1256-1263
32. Steen VD, Medsger TA (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43:2437-2444